A biopharmaceutical company developing therapies for myeloproliferative neoplasms (MPNs)
alethiotherapeutics.comOxford, UK
5 sources · checked 1 time, last 1h ago
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A | $90M | 2026-11-05 | RA Capital Management, Sofinnova Partners | 3 outlets. #57 in Trending |
5 sources · checked 1 time, last 1h ago [ VERIFIED ] read against 3 of 5 sources [ BUILT WITH ]·[ SEARCH ]found on a watched publisher·[ SCRAPE ]5 pages read: finsmes.com, manilatimes.net, finance.yahoo.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 3 of 5 sources·[ BRANDING ]logo and colour from the homepage | ||||